Axsome Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 191.2M | 196.0M | 171.0M | 150.0M | 121.5M | 118.8M | 104.8M | 87.2M |
| Cost of Goods Sold | 14.7M | 12.3M | 11.9M | 13.4M | 9.8M | 10.5M | 8.4M | 8.1M |
| Gross Profit | 176.5M | 183.7M | 159.1M | 136.6M | 111.7M | 108.3M | 96.3M | 79.1M |
| R&D Expenses | 52.7M | 48.8M | 40.2M | 49.5M | 44.8M | 55.0M | 45.4M | 49.9M |
| Operating Expenses | 239.8M | 213.1M | 205.2M | 173.3M | 168.7M | 180.9M | 158.9M | 157.2M |
| Operating Income | -63.4M | -29.4M | -46.1M | -36.7M | -57.0M | -72.6M | -62.6M | -78.0M |
| Other Income / Gains | -1.2M | 1.3M | -1.1M | -12.2M | -2.4M | -2.2M | -2.0M | -1.3M |
| Net Income | -64.5M | -28.6M | -47.2M | -48.0M | -59.4M | -74.9M | -64.6M | -79.3M |
| EPS (Diluted) | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.923 | 0.937 | 0.93 | 0.91 | 0.919 | 0.911 | 0.919 | 0.908 |
| General And Administrative Expenses | 185.0M | 0 | 108.8M | 94.3M | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 41.4M | 36.0M | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 185.0M | 169.3M | 150.2M | 130.3M | 120.8M | 113.3M | 95.6M | 103.6M |
| Other Expenses | 2.2M | -5.0M | 14.8M | -6.5M | 3.1M | 12.6M | 18.0M | 3.8M |
| Cost And Expenses | 254.6M | 225.4M | 217.1M | 186.8M | 178.4M | 191.4M | 167.4M | 165.2M |
| Interest Income | 0 | 2.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.2M | 1.2M | 1.1M | 1.8M | 2.4M | 2.2M | 2.0M | 1.3M |
| Depreciation And Amortization | 2.3M | 2.3M | 1.7M | 2.2M | 2.1M | 2.1M | 2.1M | 2.0M |
| Ebitda | -61.1M | -24.7M | -44.4M | -42.6M | -54.8M | -70.5M | -60.6M | -76.1M |
| Ebitdaratio | -0.319 | -0.126 | -0.26 | -0.284 | -0.452 | -0.594 | -0.578 | -0.873 |
| Operating Income Ratio | -0.331 | -0.15 | -0.27 | -0.245 | -0.469 | -0.611 | -0.598 | -0.895 |
| Income Before Tax | -64.5M | -28.1M | -47.2M | -48.9M | -59.4M | -74.8M | -64.6M | -79.3M |
| Income Before Tax Ratio | -0.338 | -0.144 | -0.276 | -0.326 | -0.489 | -0.63 | -0.617 | -0.91 |
| Income Tax Expense | 0 | 430K | 0 | -960K | 0 | 85K | 0 | 0 |
| Net Income Ratio | -0.338 | -0.146 | -0.276 | -0.32 | -0.489 | -0.631 | -0.617 | -0.91 |
| Epsdiluted | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 |
| Weighted Average Shs Out | 51.2M | 50.6M | 50.0M | 49.4M | 48.9M | 48.5M | 48.1M | 47.6M |
| Weighted Average Shs Out Dil | 51.2M | 50.6M | 50.0M | 49.4M | 48.9M | 48.5M | 48.1M | 47.6M |